Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma

SIMPLE SUMMARY: Several retrospective studies tried to assess the prognostic role of different sites of metastases in patients with advanced HCC, but results are often contradictory. These studies also presented results based on population samples with several confounding factors. Although the thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Ielasi, Luca, Tovoli, Francesco, Tonnini, Matteo, Stefanini, Bernardo, Tortora, Raffaella, Magini, Giulia, Sacco, Rodolfo, Pressiani, Tiziana, Trevisani, Franco, Garajová, Ingrid, Piscaglia, Fabio, Granito, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000514/
https://www.ncbi.nlm.nih.gov/pubmed/36900314
http://dx.doi.org/10.3390/cancers15051523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000514/
https://www.ncbi.nlm.nih.gov/pubmed/36900314
http://dx.doi.org/10.3390/cancers15051523

Ejemplares similares